Backbone modification alters the efficacy of antisense oligonucleotides directed against mRNA encoding either TGF-alpha or EGFR in the treatment of prostate cancer cell lines.

Source:http://linkedlifedata.com/resource/pubmed/id/12616956

Download in:

View as

General Info

PMID
12616956